Technical Analysis for OGEN - Oragenics, Inc.

Grade Last Price % Change Price Change
F 1.41 0.71% 0.01
OGEN closed up 0.71 percent on Monday, March 18, 2024, on 2.22 times normal volume. The bears made the stock sink to a new 52-week low. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Hammer Candlestick Bullish 0.00%
Lizard Bullish Bullish Day Trade Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Death Cross Bearish 0.71%
New 52 Week Closing Low Bearish 0.71%
180 Bearish Setup Bearish Swing Setup 0.71%
Narrow Range Bar Range Contraction 0.71%

   Recent Intraday Alerts

Alert Time
2x Volume Pace about 10 hours ago
1.5x Volume Pace about 10 hours ago
Possible Pocket Pivot about 10 hours ago
Down 5% about 12 hours ago
Down 3% about 12 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Oragenics, Inc. Description

Oragenics, Inc., a healthcare company, engages in the discovery, development, and commercialization of various technologies associated with oral health, antibiotics, and other general health benefits in the United States and internationally. It develops ProBiora3, an oral care probiotics technology for oral health, teeth whitening, and breath freshening for humans and pets. The company's ProBiora3 products include flavored probiotic tablets, such as EvoraPlus for daily use by adults and EvoraKids for daily use by children after brushing their teeth; EvoraPet for companion pets, including cats and dogs; and EvoraPro, a professional strength version of EvoraPlus. Its product pipeline consists of LPT3-04, a naturally occurring compound for weight loss; SMaRT Replacement Therapy, a topical treatment applied to the teeth to protect against tooth decay; and MU1140-S, an antibiotic product candidate in preclinical testing for healthcare-associated infections. Oragenics, Inc. offers its ProBiora3 products through direct-to-consumer channels, professional offices, and private label partnerships. The company was formerly known as Oragen, Inc. The company was founded in 1996 and is headquartered in Tampa, Florida.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Health Care Pet Antibiotics Dog Various Technologies Digestive System Oral Hygiene Bacteriology Weight Loss Probiotics

Is OGEN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 7.74
52 Week Low 1.26
Average Volume 97,914
200-Day Moving Average 3.56
50-Day Moving Average 3.39
20-Day Moving Average 1.97
10-Day Moving Average 1.44
Average True Range 0.26
RSI (14) 26.47
ADX 44.03
+DI 11.29
-DI 39.30
Chandelier Exit (Long, 3 ATRs) 3.11
Chandelier Exit (Short, 3 ATRs) 2.04
Upper Bollinger Bands 3.64
Lower Bollinger Band 0.30
Percent B (%b) 0.33
BandWidth 169.77
MACD Line -0.58
MACD Signal Line -0.62
MACD Histogram 0.0463
Fundamentals Value
Market Cap 4.34 Million
Num Shares 3.08 Million
EPS -4.60
Price-to-Earnings (P/E) Ratio -0.31
Price-to-Sales 324.82
Price-to-Book 2.49
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.70
Resistance 3 (R3) 1.68 1.56 1.65
Resistance 2 (R2) 1.56 1.49 1.57 1.63
Resistance 1 (R1) 1.49 1.45 1.43 1.51 1.62
Pivot Point 1.37 1.37 1.35 1.38 1.37
Support 1 (S1) 1.30 1.30 1.24 1.32 1.20
Support 2 (S2) 1.18 1.26 1.19 1.19
Support 3 (S3) 1.11 1.18 1.17
Support 4 (S4) 1.13